Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 397

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Cancer cell metabolism: implications for therapeutic targets

Open access
Jang, Miran, Kim, Sung Soo, Lee, Jinhwa·2013·Experimental & Molecular Medicine

Abstract

Cancer cell metabolism is characterized by an enhanced uptake and utilization of glucose, a phenomenon known as the Warburg effect. The persistent activation of aerobic glycolysis in cancer cells can be linked to activation of oncogenes or loss of tumor suppressors, thereby fundamentally advancing cancer progression. In this respect, inhibition of glycolytic capacity may contribute to an anticancer effect on malignant cells. Understanding the mechanisms of aerobic glycolysis may present a new basis for cancer treatment. Accordingly, interrupting lactate fermentation and/or other cancer-promoting metabolic sites may provide a promising strategy to halt tumor development. In this review, we will discuss dysregulated and reprogrammed cancer metabolism followed by clinical relevance of the metabolic enzymes, such as hexokinase, phosphofructokinase, pyruvate kinase M2, lactate dehydrogenase, pyruvate dehydrogenase kinase and glutaminase. The proper intervention of these metabolic sites may provide a therapeutic advantage that can help overcome resistance to chemotherapy or radiotherapy. The unique metabolic characteristics of cancer cells can be exploited to develop new therapies that either halt tumor growth directly or prevent the evolution of resistance to other drugs. A team led by Sung Soo Kim of Kyung Hee University in Seoul, Korea, has reviewed the ways in which cellular metabolism is rewired in cancer. Most notably, cancer cells use much more glucose than normal cells for energy production. Mutations in genes that encode metabolic enzymes — including hexokinase, lactate dehydrogenase, glutaminase and others — are often responsible for the altered energy use profile. Many drug development teams are now actively searching for compounds that can inhibit these enzymes. Kim and colleagues note that such agents may work as standalone treatments or to enhance the efficacy of common radio- and chemotherapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2013.85

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 90 references

Cited by

See all 397

Metadata

Authors
Jang, M., Kim, S. S., & Lee, J.
Venue
Experimental & Molecular Medicine
Published
2013-10-04
Volume
45
Issue
10
Pages
e45-e45
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2086965865
Cited by
397
References
90
FWCI
9.31
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer cell metabolism: implications for therapeutic targets. https://app.cochat.ai/papers/10.1038/emm.2013.85
The paper
Jang, M., Kim, S. S., & Lee, J. (2013). Cancer cell metabolism: implications for therapeutic targets. Experimental & Molecular Medicine. https://doi.org/10.1038/emm.2013.85

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.